IP Library Granted Patent US 12,351,746
Granted Patent B2
US 12,351,746 · App. 17/444,210 · Granted Jul 8, 2025

Two-part, cyanoacrylate/free radically curable adhesive systems

Inventors: Jesse L. Davis (Hartford, CT); Chetan Hire (Glastonbury, CT); Shabbir T. Attarwala (Simsbury, CT)
Assignee: Henkel AG & Co. KGaA
C09J4/00C08F220/20C08F220/36C08F222/102C08F222/103C08K5/14C08L23/0853C08L75/14C09J2301/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,351,746
App. No.
17/444,210
Granted
Jul 8, 2025
Kind
B2
Abstract

Two-part cyanoacrylate/free radically curable adhesive systems demonstrating improved toughness are provided.

Claims (34)

1. A two-part curable composition comprising:

(a) a first part comprising a cyanoacrylate component and a peroxide catalyst; and

(b) a second part comprising a free radical curable component and a transition metal, wherein at least one of the first part or the second part further comprises a (meth)acrylate-functionalized compound having a Tg of less than about 0° C., and wherein when mixed together the peroxide catalyst initiates cure of the free radical curable component and the transition metal initiates cure of the cyanoacrylate component, wherein the (meth)acrylate-functionalized compound is a (meth)acrylate-functionalized urethane resin made with an isophorane diisocyanate.

2. The composition of claim 1 , wherein the cyanoacrylate component comprises H 2 C═C(CN)—COOR, wherein R is selected from alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups.

3. The composition of claim 1 , wherein the peroxide catalyst comprises perbenzoates.

4. The composition of claim 1 , wherein the peroxide catalyst is t-butyl perbenzoate.

5. The composition of claim 1 , wherein the (meth)acrylate-functionalized compound is present in the second part.

6. The composition of claim 1 , wherein the peroxide catalyst is present in an amount from about 0.01 percent to about 10 percent by weight, based on the cyanoacrylate component.

7. The composition of claim 1 , wherein the transition metal comprises a member selected from the group consisting of copper, vanadium, cobalt and iron.

8. The composition of claim 1 , wherein the first part is housed in a first chamber of a dual chamber syringe and the second part is housed in a second chamber of the dual chamber syringe.

9. The composition of claim 1 , wherein the second part further comprises at least one of a plasticizer and a filler.

10. The composition of claim 1 , wherein the first part further comprises a toughener.

11. The composition of claim 10 , wherein the toughener is a member selected from the group consisting of (a) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (b) dipolymers of ethylene and methyl acrylate, (c) combinations of (a) and (b), (4) vinylidene chloride-acrylonitrile copolymers, (5) and vinyl chloride/vinyl acetate copolymer, (6) copolymers of polyethylene and polyvinyl acetate, and combinations thereof.

12. The composition of claim 1 , wherein when disposed between two substrates spaced apart by about 1 mm, reaction products thereof demonstrate a drop impact strength of about 5 Joules or greater.

13. The composition of claim 1 , wherein the (meth)acrylate-functionalized compound has a Tg within the range of less than about 0° C. to about −120° C.

14. The composition of claim 1 , wherein the (meth)acrylate-functionalized compound is present in an amount of about 15 to about 50 percent by weight of the free radical curable component of the second part of the composition.

15. The composition of claim 1 , wherein cured reaction products of the composition demonstrate a greater drop impact strength on substrates bonded together in a 1 mm spaced apart relationship than on substrates bonded together in a 0 mm spaced apart relationship.

16. A two-part curable composition comprising:

(a) a first part comprising a cyanoacrylate component and a peroxide catalyst; and

(b) a second part comprising a free radical curable component and a transition metal, wherein at least one of the first part or the second part further comprises a (meth)acrylate-functionalized compound having a Tg of less than about 0° C., and wherein when mixed together the peroxide catalyst initiates cure of the free radical curable component and the transition metal initiates cure of the cyanoacrylate component, wherein the (meth)acrylate-functionalized compound is a polyester urethane acrylate.

17. The composition of claim 16 , wherein the cyanoacrylate component comprises H 2 C═C(CN)—COOR, wherein R is selected from alkyl, alkoxyalkyl, cycloalkyl, alkenyl, aralkyl, aryl, allyl and haloalkyl groups.

18. The composition of claim 16 , wherein the peroxide catalyst comprises perbenzoates.

19. The composition of claim 16 , wherein the peroxide catalyst is t-butyl perbenzoate.

20. The composition of claim 16 , wherein the (meth)acrylate-functionalized compound is present in the second part.

21. The composition of claim 16 , wherein the peroxide catalyst is present in an amount from about 0.01 percent to about 10 percent by weight, based on the cyanoacrylate component.

22. The composition of claim 16 , wherein the transition metal comprises a member selected from the group consisting of copper, vanadium, cobalt and iron.

23. The composition of claim 16 , wherein the first part is housed in a first chamber of a dual chamber syringe and the second part is housed in a second chamber of the dual chamber syringe.

24. The composition of claim 16 , wherein the second part further comprises at least one of a plasticizer and a filler.

25. The composition of claim 16 , wherein the first part further comprises a toughener.

26. The composition of claim 25 , wherein the toughener is a member selected from the group consisting of (a) reaction products of the combination of ethylene, methyl acrylate and monomers having carboxylic acid cure sites, (b) dipolymers of ethylene and methyl acrylate, (c) combinations of (a) and (b), (4) vinylidene chloride-acrylonitrile copolymers, (5) and vinyl chloride/vinyl acetate copolymer, (6) copolymers of polyethylene and polyvinyl acetate, and combinations thereof.

27. The composition of claim 16 , wherein when disposed between two substrates spaced apart by about 1 mm, reaction products thereof demonstrate a drop impact strength of about 5 Joules or greater.

28. The composition of claim 16 , wherein the (meth)acrylate-functionalized compound has a Tg within the range of less than about 0° C. to about −120° C.

29. The composition of claim 16 , wherein the (meth)acrylate-functionalized compound is present in an amount of about 15 to about 50 percent by weight of the free radical curable component of the second part of the composition.

30. The composition of claim 16 , wherein cured reaction products of the composition demonstrate a greater drop impact strength on substrates bonded together in a 1 mm spaced apart relationship than on substrates bonded together in a 0 mm spaced apart relationship.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2022
From: HENKEL IP & HOLDING GMBH
To: HENKEL AG & CO. KGAA
Reel/Frame 059207/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2021
From: HIRE, CHETAN; DAVIS, JESSE L.; ATTARWALA, SHABBIR T.
To: HENKEL IP & HOLDING GMBH
Reel/Frame 058093/0347 →
Continuity (3)
Continuation PCTUS2020017598 · Feb 11, 2020
Provisional Application 62803874 · Feb 11, 2019
Related Publication 20210363386A1 · Nov 25, 2021
References Cited (33)
US 3183217A · Serniuk et al. · 1965 [cited by applicant]
US 3963772A · Takeshita · 1976 [cited by applicant]
US 4102945A · Gleave · 1978 [cited by applicant]
US 4440910A · O'Connor · 1984 [cited by applicant]
US 4444933A · Columbus et al. · 1984 [cited by applicant]
US 4556700A · Harris et al. · 1985 [cited by applicant]
US 4560723A · Millet et al. · 1985 [cited by applicant]
US 4622414A · Mckervey · 1986 [cited by applicant]
US 4636539A · Harris et al. · 1987 [cited by applicant]
US 4695615A · Leonard et al. · 1987 [cited by applicant]
US 4718966A · Harris et al. · 1988 [cited by applicant]
US 4837260A · Sato et al. · 1989 [cited by applicant]
US 4855461A · Harris et al. · 1989 [cited by applicant]
US 4906317A · Liu · 1990 [cited by applicant]
US 5312864A · Wenz et al. · 1994 [cited by applicant]
US 5340873A · Mitry · 1994 [cited by applicant]
US 5382635A · Mcinnis et al. · 1995 [cited by applicant]
US 5506283A · Mcinnis et al. · 1996 [cited by applicant]
US 5530037A · Mcdonnell et al. · 1996 [cited by applicant]
US 5693714A · Bauman et al. · 1997 [cited by applicant]
US 5969053A · Bauman et al. · 1999 [cited by applicant]
US 5994464A · Ohsawa et al. · 1999 [cited by applicant]
US 6562181B2 · Righettini · 2003 [cited by applicant]
US 6607632B1 · Mcdonnell et al. · 2003 [cited by applicant]
US 6833196B1 · Wojciak · 2004 [cited by applicant]
US 9371470B2 · Barnes et al. · 2016 [cited by applicant]
US 20090298969A1 · Attarwala et al. · 2009 [cited by applicant]
US 20140275419A1 · Ward et al. · 2014 [cited by applicant]
US 20140329959A1 · Barnes et al. · 2014 [cited by applicant]
WO 2013111036A1 · 2013 [cited by applicant]
WO 2020082060A1 · 2020 [cited by applicant]
International Search Report issued in connection of International Patent Application No. PCT/US2020/017598 mailed on Jun. 5, 2020. [cited by applicant]
Supplementary European Search Report issued Oct. 17, 2022. [cited by applicant]